Teresa R Gray

Summary

Publications

  1. pmc Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence
    Teresa R Gray
    Chemistry and Drug Metabolism, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Blvd, Suite 200, Room 05A721, Baltimore, MD 21224, USA
    Forensic Sci Int 206:98-102. 2011
  2. pmc Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes
    Ana de Castro
    Chemical and Drug Metabolism Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA
    Ther Drug Monit 33:443-52. 2011
  3. doi request reprint Maternal methadone dose, placental methadone concentrations, and neonatal outcomes
    Ana de Castro
    Chemistry and Drug Metabolism, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA
    Clin Chem 57:449-58. 2011
  4. pmc New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, NIH, Baltimore, MD, USA
    Clin Chem 56:856-60. 2010
  5. pmc Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study
    Teresa R Gray
    Chemistry and Drug Metabolism, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA
    Ther Drug Monit 31:769-75. 2009
  6. pmc Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA
    Addiction 105:2151-9. 2010
  7. pmc Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA
    Clin Chem 56:1442-50. 2010
  8. pmc Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA
    Nicotine Tob Res 12:658-64. 2010
  9. pmc Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Blvd, Baltimore, MD 21224, USA
    Clin Chem 54:2018-27. 2008
  10. pmc Effect of hydrolysis on identifying prenatal cannabis exposure
    Teresa R Gray
    Chemistry and Drug Metabolism, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Blvd Suite 200, Room 05A721A, Baltimore, MD, USA
    Anal Bioanal Chem 397:2335-47. 2010

Detail Information

Publications12

  1. pmc Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence
    Teresa R Gray
    Chemistry and Drug Metabolism, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Blvd, Suite 200, Room 05A721, Baltimore, MD 21224, USA
    Forensic Sci Int 206:98-102. 2011
    ..Oral fluid testing is widely used for detecting drug exposure, but data describing methadone and metabolites in oral fluid during pharmacotherapy for opioid-dependence are relatively limited...
  2. pmc Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes
    Ana de Castro
    Chemical and Drug Metabolism Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA
    Ther Drug Monit 33:443-52. 2011
    ....
  3. doi request reprint Maternal methadone dose, placental methadone concentrations, and neonatal outcomes
    Ana de Castro
    Chemistry and Drug Metabolism, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA
    Clin Chem 57:449-58. 2011
    ....
  4. pmc New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, NIH, Baltimore, MD, USA
    Clin Chem 56:856-60. 2010
    ..The presence of the MAMP metabolites p-hydroxymethamphetamine (pOHMAMP), p-hydroxyamphetamine (pOHAMP), and norephedrine (NOREPH) in meconium may improve the identification of MAMP- and AMP-exposed neonates...
  5. pmc Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study
    Teresa R Gray
    Chemistry and Drug Metabolism, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA
    Ther Drug Monit 31:769-75. 2009
    ..Low confirmation rates in meconium reinforce the need for confirmatory testing following positive screening results and additional research to identify alternative biomarkers...
  6. pmc Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA
    Addiction 105:2151-9. 2010
    ..This research evaluated whether quantification of fetal methadone and drug exposure via meconium would reflect maternal dose and predict neonatal outcomes...
  7. pmc Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA
    Clin Chem 56:1442-50. 2010
    ..Testing of meconium, the first neonatal feces, offers objective evidence of prenatal cannabis exposure, but the relative ability of meconium testing and maternal self-report to identify affected neonates remains unclear...
  8. pmc Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA
    Nicotine Tob Res 12:658-64. 2010
    ..However, relationships between the amount, frequency, and timing of cigarette smoking during gestation and tobacco biomarker meconium concentrations and neonatal outcomes are unclear...
  9. pmc Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Blvd, Baltimore, MD 21224, USA
    Clin Chem 54:2018-27. 2008
    ....
  10. pmc Effect of hydrolysis on identifying prenatal cannabis exposure
    Teresa R Gray
    Chemistry and Drug Metabolism, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Blvd Suite 200, Room 05A721A, Baltimore, MD, USA
    Anal Bioanal Chem 397:2335-47. 2010
    ..Maximal identification of cannabis-exposed neonates and the widest range of cannabis biomarkers are achieved with enzyme-alkaline tandem hydrolysis...
  11. pmc A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Blvd, Baltimore, MD 21224, USA
    Anal Bioanal Chem 393:1977-90. 2009
    ..Method applicability was demonstrated by analyzing meconium from drug-exposed neonates...
  12. pmc Novel biomarkers of prenatal methamphetamine exposure in human meconium
    Teresa R Gray
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA
    Ther Drug Monit 31:70-5. 2009
    ..Novel methamphetamine biomarker concentrations were characterized in meconium of infants exposed in utero to MAMP...